Gemcitabine-induced erysipeloid skin lesions in a patient with malignant mesothelioma
Küçük Resim Yok
Tarih
2002
Yazarlar
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
European Acad Dermatology & Venereology
Erişim Hakkı
info:eu-repo/semantics/closedAccess
Özet
Gemcitabine is a nucleoside analogue that has shown to have antineoplastic activity in different solid tumours (lung, pancreas, bladder, colon, ovarian, and breast cancer) and malignant mesothelioma. The toxic effects of gemcitabine include myelosuppression, flu-like syndrome, altered liver function tests, bronchospasm, rash, itching, and fever. However, gemcitabine-induced erysipeloid skin reaction was reported in a small number of patients with previous history of radiotherapy or lymphedema. We reported a male patient who developed erysipeloid skin reaction following gemcitabine treatment in the absence of radiotherapy and lymphedema.
Açıklama
Anahtar Kelimeler
gemcitabine, erysipeloid skin reaction, malignant mesothelioma
Kaynak
Journal of The European Academy of Dermatology and Venereology
WoS Q Değeri
Q2
Scopus Q Değeri
Q1
Cilt
16
Sayı
3
